type 2
Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK
September 2, 2020Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes
Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …
Arthritis drug Abatacept could be used to treat type 1 diabetes
August 11, 2020Manufacturing and Production diabetes, insulin, tye 1, type 2
People with type 1 diabetes could see their lives extended by the arthritis drug Abatacept, new study finds. Researchers at …
Drug industry suing to overturn Minnesota insulin affordability law
July 2, 2020Business Services diabetes, insulin, type 1, type 2
The drug industry is suing to overturn a Minnesota law that requires companies to provide emergency insulin to diabetics who …
Insulin pumps tied to over 2,000 injuries recalled
February 14, 2020Medical Communications Type 1 diabetes, diabetes, insulin, type 1, type 2, type 2 diabetes
Over 300,000 insulin pumps have been recalled by Medtronic after injuries and one death were reported due to devices malfunctioning. …
Type 2 diabetes drug Rosiglitazone increases risk of heart problems
February 12, 2020Research and Development British Medical Journal, diabetes, heart failure, insulin, type 2, type 2 diabetes
A new study has given further evidence that rosiglitazone can contribute to risk of heart problems and heart failure. The …
Less sleep in children linked to increased risk of diabetes
August 16, 2017Research and Development biotech, diabetes, drugs, pharma, pharmaceutical, type 2, type-2
A study emerging from St George’s University of London found that children who slept an hour less than the recommended …
FDA delays appraisal of Sanofi, Zealand diabetes drug just days before decision due
August 22, 2016Research and Development, Sales and Marketing NDA, Sanofi, appraisal, diabetes, iglarlixi, type 2, type-2, zealand
There was unfortunate news for Sanofi and Zealand Pharma as the FDA announced that it required additional information, constituting a …
Sanofi gets FDA approval for type-2 diabetes treatment Adlyxin
July 28, 2016Research and Development, Sales and Marketing FDA, Lixisenatide, Lyxumia, Sanofi, adlyxin, approval, diabetes, type 2, type-2, zealand
Sanofi has announced that the US Food and Drug Administration (FDA) has approved Adlyxin (lixisenatide), which is a once-daily mealtime …
FDA approves Lilly/Boehringer Ingelheim type-2 diabetes drug
June 1, 2016Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, diabetes, jentadueto, jentadueto xr, lilly, partnership, type 2, type-2
The US Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin and metformin hydrochloride extended release) tablets for the …
Sun Pharma agree deal to distribute AstraZeneca type-2 diabetes drug in India
March 24, 2016Sales and Marketing AstraZeneca, India, Sun Pharma, diabetes, oxra, type 2, type-2
Sun Pharma has agreed a deal with AstraZeneca to promote and distribute their type-2 diabetes drug, dapagliflozin, in India. Marketed …
Takeda pays $2.7 billion to settle Actos lawsuits
May 1, 2015Sales and Marketing Actos, FDA, Takeda, bladder, lilly, pioglitazone, type 2
Takeda has agreed to pay $2.7 billion to finally settle thousands of US lawsuits claiming its diabetes drug Actos can …
FDA approves novel obesity device
January 16, 2015Medical Communications, Sales and Marketing EnteroMedics, FDA, Novo, VBLOC, diabetes, obesity, type 2
The US Food and Drug Administration has shown the green light to US firm EnteroMedics’ new obesity device VBLOC that …
NICE changes insulin advice in diabetes guidelines
December 12, 2014Sales and Marketing NHS, NICE, diabetes, health survey, insulin, type 1, type 2
NICE has changed its recommendations on type 1 diabetes in adults and children, and type 2 diabetes in children, to …
Analysis finds no Actos bladder cancer link
December 8, 2014Sales and Marketing Actos, Cancer, Takeda, bladder, lilly, pioglitazone, type 2
A large-scale analysis of patient data has found that pioglitazone, the diabetes drug that is the subject of ongoing safety …
Latest content
FibroFind appoints Lee Borthwick as CEO
